BCL2 and leukemia: 753B PROTAC, which causes BCL-XL/BCL-2 ubiquitination and selective degradation of cells expressing VHL, is an innovative approach to inducing apoptosis activation and eliminating chemotherapy-induced senescent leukemia cells [88].